CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Cardiopulmonary Bypass with Two Different Intra-Operative Hematocrits +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00006183
NCT00006183Phase 3Completed
CompareCT.gov

Hematocrit Strategy in Infant Heart Surgery

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Aug 22, 2000·Updated Jul 29, 2016

In Brief

A Phase 3 clinical trial evaluating Cardiopulmonary Bypass with Two Different Intra-Operative Hematocrits and Thoracic Surgery for Cardiovascular Diseases and 3 related conditions. Completed, across 1 site.

Detailed Summary

The purpose of this study is to compare the effects of diluted hematocrit (HCT) levels of 35% versus 25% during hypothermic cardiopulmonary bypass (CPB) in infants with d-transposition of the great arteries, a malformation of the heart vessels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Heart Defects, Congenital, Transposition of Great Vessels
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 22, 2000
Enrollment StartJul 1, 2000
Primary CompletionJul 1, 2005
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 25.9 years ago

Interventions

Cardiopulmonary Bypass with Two Different Intra-Operative Hematocritsprocedure

Thoracic Surgeryprocedure